Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentian Violet vs Nystatin for Oropharyngeal Candidiasis in Children
NCT00128323Phase 3Completed
- Start
- Nov 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gentian violet in oropharyngeal candidiasis (OPC) (3 arms). Primary endpoints: Clinical clearance of oral candidiasis at 12 days and Fungal clearance of oral candidiasis by saliva culture at 12 days. Started Nov 2002; status: completed.
02
Drugs
gentian violet
03
Conditions
oropharyngeal candidiasis (OPC)
Beyond the preview
Go deeper on NCT00128323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128323.